Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 23586591)

1.

Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.

Tietz HJ, Hay R, Querner S, Delcker A, Kurka P, Merk HF.

Mycoses. 2013 Jul;56(4):414-21. doi: 10.1111/myc.12037. Epub 2013 Apr 16.

PMID:
23586591
2.

Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.

Friedman-Birnbaum R, Cohen A, Shemer A, Bitterman O, Bergman R, Stettendorf S.

Int J Dermatol. 1997 Jan;36(1):67-9.

PMID:
9071624
3.

Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.

Lahfa M, Bulai-Livideanu C, Baran R, Ortonne JP, Richert B, Tosti A, Piraccini BM, Szepietowski JC, Sibaud V, Coubetergues H, Voisard JJ, Paul C.

Dermatology. 2013;226(1):5-12. doi: 10.1159/000345105. Epub 2013 Mar 1.

PMID:
23467055
4.

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.

Gupta AK, Fleckman P, Baran R.

J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S70-80.

PMID:
11051136
5.

[Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea].

Tsuboi R, Unno K, Komatsuzaki H, Ogawa H, Kasai T, Oka K, Takiuchi I, Kitamura K, Higashi N, Nakashima Y, Nishimoto K.

Nihon Ishinkin Gakkai Zasshi. 1998;39(1):11-6. Japanese.

6.

Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.

Syed TA, Ahmadpour OA, Ahmad SA, Shamsi S.

J Dermatol. 1998 Oct;25(10):648-52.

PMID:
9830263
7.

Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study.

Emtestam L, Kaaman T, Rensfeldt K.

Mycoses. 2012 Nov;55(6):532-40. doi: 10.1111/j.1439-0507.2012.02215.x. Epub 2012 Jun 11.

PMID:
22681227
8.

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.

Elewski BE, Ghannoum MA, Mayser P, Gupta AK, Korting HC, Shouey RJ, Baker DR, Rich PA, Ling M, Hugot S, Damaj B, Nyirady J, Thangavelu K, Notter M, Parneix-Spake A, Sigurgeirsson B.

J Eur Acad Dermatol Venereol. 2013 Mar;27(3):287-94. doi: 10.1111/j.1468-3083.2011.04373.x. Epub 2011 Dec 20.

PMID:
22181693
9.

Treatment of onychomycosis with a bifonazole-urea combination.

Hardjoko FS, Widyanto S, Singgih I, Susilo J.

Mycoses. 1990 Apr;33(4):167-71.

PMID:
2146498
10.

Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole.

Torres-Rodríguez JM, Madrenys N, Nicolás MC.

Mycoses. 1991 Nov-Dec;34(11-12):499-504.

PMID:
1840471
11.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S77-86.

PMID:
9631989
13.

Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.

Grover C, Bansal S, Nanda S, Reddy BS, Kumar V.

Br J Dermatol. 2007 Aug;157(2):364-8. Epub 2007 Jun 15.

PMID:
17573877
14.

A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial.

Bassiri-Jahromi S, Ehsani AH, Mirshams-Shahshahani M, Jamshidi B.

J Dermatolog Treat. 2012 Dec;23(6):453-6. doi: 10.3109/09546634.2011.588191. Epub 2011 Jul 24.

PMID:
21781012
15.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Katz HI, McDonald CJ, Muglia J, Savin RC, Webster G, Elewski BE, Leyden JJ, Bucko AD, Tschen EH, Hanifin JM, Morman MR, Shupack JL, Greer DL, et al.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S87-94.

PMID:
9631990
16.

Onychomycosis in children: treatment with bifonazole-urea.

Bonifaz A, Ibarra G.

Pediatr Dermatol. 2000 Jul-Aug;17(4):310-4.

PMID:
10990584
17.

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.

Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B; Ravuconazole onychomycosis group.

J Eur Acad Dermatol Venereol. 2005 Jul;19(4):437-43.

PMID:
15987289
18.

[Treatment of onychomycosis using 40% urea with 1% bifonazole].

Shemer A, Bergman R, Cohen A, Friedman-Birnbaum R.

Harefuah. 1992 Feb 2;122(3):159-60. Hebrew.

PMID:
1532948
19.

Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.

Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R.

J Drugs Dermatol. 2013 Feb;12(2):186-92.

PMID:
23377392
20.

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.

Sigurgeirsson B, van Rossem K, Malahias S, Raterink K.

J Am Acad Dermatol. 2013 Sep;69(3):416-25. doi: 10.1016/j.jaad.2013.03.021. Epub 2013 May 22.

PMID:
23706639
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk